Observational Study of Nutritional Changes and Body Composition in Adults with Head and Neck, Lung, or Rectal Cancer Receiving Standard Cancer Treatments

What this Trial Is About

Researchers are studying patients with head and neck squamous cell carcinoma, locally advanced rectal cancer, and lung cancer who are receiving standard cancer treatments. The study aims to observe changes in nutrition and body composition over time in these patients. This observational study supports the development of a future dietary supplement designed to reduce side effects and help patients better tolerate their cancer treatments. Participants will undergo regular assessments including dietary visits, 3-day food records, nutritional screenings, body composition analysis using bioimpedance, muscle strength tests with handgrip, blood sampling for cytokines, and quality-of-life questionnaires. These evaluations will be done at specific time points from the start of treatment through follow-up, up to approximately three months. During the study, researchers will collect data on energy intake, muscle mass, handgrip strength, body weight, nutritional risk, and inflammatory markers in the blood. They will also monitor treatment toxicity and tolerance. This comprehensive monitoring includes questionnaires and physical measurements to understand how patients nutrition and body composition evolve during cancer treatment, helping to inform future supportive nutrition research.

GALENOS 1 in Head and Neck, Lung, and Rectal Cancer Patients